Juan Felix Espinosa
Associate VP Biophysics, Early Molecule Discovery, Lilly
Juan Felix Espinosa is listed as Associate VP Biophysics, Early Molecule Discovery, Lilly. Juan spoke at Drug Discovery Chemistry Europe 2026 in November 2026 (moderator, “Biophysical Approaches for Small Molecule Lead Generation”). Speaks mainly at Hospitals and Health Care events.
Compiled from published conference agendas; not yet confirmed by Juan. Is this you? Claim this profile.
- Sector: Hospitals and Health Care
About
Dr. Juan F. Espinosa earned his Ph.D. in Chemistry from the Spanish Research Council in 1998, studying the solution and protein-bound conformations of C-disaccharide ligands under Prof. Jesús Jiménez-Barbero. He carried out research stays at the University of Lübeck, the German Cancer Research Center, and CERMAV-Grenoble before completing a Fulbright-supported postdoctoral fellowship at the University of Wisconsin-Madison, where he worked on the design and conformational analysis of beta-hairpin forming peptides with Prof. Samuel Gellman. He joined Lilly Research Laboratories in Spain in 2000, progressing through a series of scientific and leadership roles to his current position as Associate Vice President, where he leads the biophysics group at the Spanish Lilly site.
Sessions at 1 conference
Drug Discovery Chemistry Europe 2026 11 November 2026 – 12 November 2026
- Biophysical Approaches for Small Molecule Lead Generation Moderator · 11 November 2026
Spoke alongside
People who have shared a session with Juan at events on B2DB.
- Stefan Geschwindner Director Biophysics · AstraZeneca 1 shared session